Cargando…
Beginning of a new era in glucagon research: Breakthrough by the new glucagon assay
There is a new concept of diabetes as a “comprehensive nutrition disorder”, caused due to both insulin and glucagon dysregulation. Dysregulated glucagon secretion in α‐cells exacerbates multiple metabolic disorders: glycemic control and amino acid metabolism, together with insulin deficiency.[Image:...
Autor principal: | Kawamori, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477516/ https://www.ncbi.nlm.nih.gov/pubmed/32299149 http://dx.doi.org/10.1111/jdi.13275 |
Ejemplares similares
-
New perspectives on insulin therapy
por: Araki, Eiichi, et al.
Publicado: (2020) -
Updates in diabetic neuropathy: A call for new diagnostic and treatment approaches
por: Aso, Yoshimasa
Publicado: (2021) -
New prospects for incretin‐related drugs in the treatment of type 2 diabetes
por: Kimura, Tomohiko, et al.
Publicado: (2020) -
A new perspective on the biguanide, metformin therapy in type 2 diabetes and lactic acidosis
por: Hotta, Nigishi
Publicado: (2019) -
New perspective on type 2 diabetes, dyslipidemia and non‐alcoholic fatty liver disease
por: Matsuzaka, Takashi, et al.
Publicado: (2020)